• Novel Milk Protein Ingredients.

      Kelly, Philip; O'Kennedy, Brendan; Cribbin, M. (Teagasc, 2001-05-01)
      The manufacture of casein/caseinates containing whey protein is immediately attractive due to its potential to enhance product yield. However, some technologies capable of producing these products are ineligible for manufacturing subsidy because of restrictions pertaining to relevant EU regulations. Other emerging technologies require refinement and process design before implementation at industrial level. Furthermore, the implications of incorporating virtually the entire complement of whey protein in what is essentially a caseinate ingredient needs to be investigated carefully in terms of the versatility of use in a wide range of food formulations. The development is significant in the context of U.S. market changes - traditionally, an important outlet for Irish casein exports amounting to 20,000 - 27,000 t per annum. Ireland accounts for ~ 30% of EU casein/caseinate production with the greater proportion in Rennet form (27,000 t) and the remainder (18,000 t) as Acid casein. In recent years, a new market for a related casein ingredient - milk protein concentrate (MPC) opened up in the US, and accounted for total imports of 40,000 t in 1998, 10,000 t of which were exported from Ireland. However, this market is more restricted due to regulatory changes introduced in response to the perceived threat of MPC imports to the US dairy industry. Since casein, or its derivative products such as milk proteinate (EU Annex III compliant), are not perceived to be in competition with local milk supplies and dairy ingredients, it is now hoped that Irish casein manufacturers may be able to reclaim recently lost markets through the introduction of an innovative proteinate ingredient which is expected to command a premium in nutrition applications e.g. in sports, infant formula and nutraceutical products. With a choice of emerging new technologies for the production of novel casein-related ingredients, the dairy industry has an opportunity to decide on what is appropriate for the defence of its market share and at the same time benefit from simultaneous compliance with relevant regulatory supports (EU) and market access rules (USA). Hence the main aims of this project were: * To investigate new technologies for the isolation of casein and casein/whey protein combinations in the course of developing new milk protein ingredients, and * To compare the performance in selected food formulations of novel milk protein ingredients namely milk proteinates, milk protein concentrates, native phosphocasein and classical Annex III casein products.